EUVIMEDEUVIMED entdecken
Kommentar

Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?

Mark Haas

Kidney International · 2024

DOI: 10.1016/j.kint.2024.03.021 ↗

Kurz gefasst

Kommentar in der Zeitschrift Kidney International, 2024. Verfasst von Mark Haas. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA. Electronic address: mark.haas@cshs.org. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Podocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Cedars-Sinai Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Oxford histopathologic classification (MEST-C: scores for lesions indicating active glomerular inflammation, mesangial [M] and endocapillary [E] hypercellularity as well as cellular or fibrocellular crescents [C], and for segmental glomerulosclerosis [S] and interstitial fibrosis and/or tubular atrophy [T]) is useful in helping assess prognosis in patients with IgA nephropathy. Elements of this classification indicative of active glomerular inflammation, endocapillary hypercellularity and crescents, also have been found to be responsive to immunosuppressive therapy, potentially including newer agents specifically targeting mediators of such inflammation. In this issue of Kidney International, Bellur and coworkers identify histopathologic subtypes of segmental glomerulosclerosis in IgA nephropathy showing podocyte injury that also behave like active lesions, including showing improved outcomes with immunosuppression. This podocyte injury, identifiable only by kidney biopsy, may represent a potential therapeutic target in some patients with IgA nephropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, IGAPodocytesHumansBiopsyImmunosuppressive AgentsGlomerulosclerosis, Focal SegmentalKidney GlomerulusPrognosis

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA. Electronic address: mark.haas@cshs.org.

Förderung

  • Cedars-Sinai Medical Center

Zitieren

APA

Haas, M. (2024). Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?. Kidney International. https://doi.org/10.1016/j.kint.2024.03.021

Vancouver

Haas M. Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?. Kidney International. 2024. doi:10.1016/j.kint.2024.03.021

BibTeX
@article{Haas2024,
  author = {Haas, Mark},
  title = {Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?},
  journal = {Kidney International},
  year = {2024},
  doi = {10.1016/j.kint.2024.03.021}
}
Kostenlos starten →